1. Home
  2. IMMX vs MVO Comparison

IMMX vs MVO Comparison

Compare IMMX & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • MVO
  • Stock Information
  • Founded
  • IMMX 2014
  • MVO 2006
  • Country
  • IMMX United States
  • MVO United States
  • Employees
  • IMMX N/A
  • MVO N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • MVO Oil & Gas Production
  • Sector
  • IMMX Health Care
  • MVO Energy
  • Exchange
  • IMMX Nasdaq
  • MVO Nasdaq
  • Market Cap
  • IMMX 61.1M
  • MVO 66.6M
  • IPO Year
  • IMMX 2021
  • MVO N/A
  • Fundamental
  • Price
  • IMMX $2.65
  • MVO $5.96
  • Analyst Decision
  • IMMX Strong Buy
  • MVO
  • Analyst Count
  • IMMX 1
  • MVO 0
  • Target Price
  • IMMX $7.00
  • MVO N/A
  • AVG Volume (30 Days)
  • IMMX 137.1K
  • MVO 55.1K
  • Earning Date
  • IMMX 08-11-2025
  • MVO 01-01-0001
  • Dividend Yield
  • IMMX N/A
  • MVO 17.46%
  • EPS Growth
  • IMMX N/A
  • MVO N/A
  • EPS
  • IMMX N/A
  • MVO 1.46
  • Revenue
  • IMMX N/A
  • MVO N/A
  • Revenue This Year
  • IMMX N/A
  • MVO N/A
  • Revenue Next Year
  • IMMX N/A
  • MVO N/A
  • P/E Ratio
  • IMMX N/A
  • MVO $7.29
  • Revenue Growth
  • IMMX N/A
  • MVO N/A
  • 52 Week Low
  • IMMX $1.26
  • MVO $8.85
  • 52 Week High
  • IMMX $3.00
  • MVO $13.95
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 61.44
  • MVO 52.90
  • Support Level
  • IMMX $2.16
  • MVO $5.65
  • Resistance Level
  • IMMX $2.80
  • MVO $5.94
  • Average True Range (ATR)
  • IMMX 0.17
  • MVO 0.19
  • MACD
  • IMMX 0.04
  • MVO 0.01
  • Stochastic Oscillator
  • IMMX 80.00
  • MVO 71.74

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About MVO MV Oil Trust Units of Beneficial Interests

MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.

Share on Social Networks: